AnaptysBio
ANAB
50 hedge funds and large institutions have $382M invested in AnaptysBio in 2017 Q1 according to their latest regulatory filings, with 50 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
68.13% more ownership
Funds ownership: 0% → 68.13% (+68%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FM
Frazier Management
Seattle,
Washington
|
+$85.9M |
| 2 |
NHAS
Novo Holdings A/S
Hellerup,
Denmark
|
+$70.7M |
| 3 |
BI
BVF Inc
San Francisco,
California
|
+$40.5M |
| 4 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
+$20.9M |
| 5 |
PA
Perceptive Advisors
New York
|
+$20.5M |
Top Sellers
ANAB Hedge Fund Activity: Q1 2017 in Review
50 of the 4,018 institutional investors tracked by Wall St. Rank reported a position in AnaptysBio (ANAB) for Q1 2017, worth a combined $382M.
Buyers outnumbered sellers: 50 funds opened new ANAB positions and 0 closed out — a net gain of 50 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Frazier Management, opening a new position worth an estimated $85.9M.
- 50 institutional investors held AnaptysBio (ANAB) as of Q1 2017, up from 0 in Q4 2016.
- Funds reported $382M of AnaptysBio stock for Q1 2017.
- 50 funds opened new AnaptysBio positions in Q1 2017 and 0 closed out, a net change of +50 holders.
- The largest AnaptysBio buyer in Q1 2017 was Frazier Management, an estimated $85.9M added.
Based on aggregated 13F filings for Q1 2017.